Stratec SE (STSEY)
OTCMKTS · Delayed Price · Currency is USD
4.990
0.00 (0.00%)
At close: Feb 5, 2026
Stratec SE Market Cap
Stratec SE has a market cap or net worth of $294.96 million as of February 12, 2026. Its market cap has decreased by -33.45% in one year.
Market Cap
294.96M
Enterprise Value
423.37M
Revenue
305.35M
Ranking
n/a
PE Ratio
16.37
Stock Price
$4.99
Market Cap Chart
Since March 1, 1999, Stratec SE's market cap has increased from 139.88M to 294.96M, an increase of 110.86%. That is a compound annual growth rate of 2.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 296.56M | -7.62% |
| Dec 30, 2025 | 321.02M | -14.59% |
| Dec 30, 2024 | 375.85M | -38.59% |
| Dec 29, 2023 | 612.03M | -41.78% |
| Dec 30, 2022 | 1.05B | -44.36% |
| Dec 30, 2021 | 1.89B | 3.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 340.99M |
| Tian'an Technology Group | 182.07M |
| Zomedica | 127.05M |
| Positron | 68.49M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 55.94M |
| Guided Therapeutics | 33.69M |
| Vivos | 32.75M |